LSTA: the cashflow

MyFinsight

For the quarter ending 2025-09-30, LSTA had $2,163K increase in cash & cash equivalents over the period. -$3,342K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-4,249	-9,383
Share-based compensation	232	769
Depreciation and amortization	44	87
Loss from equity method investment	0	0
Amortization/accretion on marketable securities	14	61
Accounts receivable	1	-399
Prepaid and other current assets	-344	-63
Other assets	-50	-90
Accounts payable, accrued liabilities and other liabilities	252	-1,322
Net cash used in operating activities	-3,342	-9,358
Purchase of marketable securities	0	9,180
Sale of marketable securities	5,150	19,144
Purchase of property and equipment	0	28
Investment in impilo therapeutics	0	0
Net cash provided by investing activities	5,150	9,936
Proceeds from exercise of options	0	8
Tax withholding payments on net share settlement equity awards	0	253
Net proceeds from issuance of common stock	353	286
Net cash provided by (used in) financing activities	353	41
Effect of exchange rate changes on cash	2	7
Net increase (decrease) in cash and cash equivalents	2,163	626
Cash and cash equivalents at beginning of period	16,209	-
Cash and cash equivalents at end of period	18,998	-

Unit: Thousand (K) dollars